Holen Sie sich die Stockscreener-App
545.83
0.04%
-0.20
Handel nachbörslich:
545.80
-0.03
-0.01%
Schlusskurs vom Vortag:
$546.03
Offen:
$546.95
24-Stunden-Volumen:
13.66M
Relative Volume:
0.76
Marktkapitalisierung:
$1.39T
Einnahmen:
$214.96B
Nettoeinkommen (Verlust:
$70.59B
KGV:
19.84
EPS:
27.5066
Netto-Cashflow:
$48.25B
1W Leistung:
-8.26%
1M Leistung:
-15.49%
6M Leistung:
-16.75%
1J Leistung:
-27.00%
1-Tages-Spanne:
$539.31
$549.99
1-Wochen-Bereich:
$537.27
$601.86
52-Wochen-Spanne:
$520.26
$790.80
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, DASH
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
545.83 | 1.39T | 214.96B | 70.59B | 48.25B | 27.51 |
GOOGL
Alphabet Inc
|
340.67 | 4.22T | 446.32B | 244.21B | 53.27B | 19.91 |
GOOG
Alphabet Inc
|
338.20 | 4.18T | 446.32B | 244.21B | 53.27B | 19.91 |
SPOT
Spotify Technology Sa
|
533.13 | 109.65B | 20.32B | 3.16B | 3.82B | 12.55 |
DASH
Doordash Inc
|
222.36 | 95.42B | 14.72B | 923.00M | 1.75B | 2.0994 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-07-16 | Fortgesetzt | Wedbush | Neutral |
| 2026-07-10 | Bestätigt | Citizens | Mkt Outperform |
| 2026-07-07 | Hochstufung | Erste Group | Hold → Buy |
| 2026-06-02 | Hochstufung | Arete | Neutral → Buy |
| 2026-05-20 | Bestätigt | Wells Fargo | Overweight |
| 2026-05-05 | Bestätigt | Mizuho | Outperform |
| 2026-04-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Bestätigt | Wolfe Research | Outperform |
| 2026-04-09 | Bestätigt | Rosenblatt | Buy |
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-03-30 | Bestätigt | Morgan Stanley | Overweight |
| 2026-03-05 | Herabstufung | Arete | Buy → Neutral |
| 2026-03-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
Top Meta Reporter: Zuckerberg Dropped a Major Hint About Meta’s Next AI Breakthrough and Nobody's Paying Attention - 24/7 Wall St.
Testimony says Meta prioritized growth, kept 'don't ask, don't tell' on under-13 users - WBFF
Meta defends child safety record amid social media addiction allegations - KOMO
Billionaire Bill Ackman Just Sold 25% of His Stake in This Big Tech Giant for 2 AI Rivals - The Motley Fool
Meta faces risks whether it wins or loses major social media trial - Yahoo Finance Singapore
Meta defends its child safety efforts but critics say the social media giant falls shortABC News - ABC News - Breaking News, Latest News and Videos
Meta becomes major AI customer of Microsoft’s Azure cloudreport - Investing.com
Meta emerges as major Microsoft Azure AI customer - Yahoo Finance
Meta becomes one of Microsoft’s largest AI customers: report - Seeking Alpha
Meta’s Trial Adds a Trillion-Dollar Risk to Its Struggling Stock - Bloomberg.com
Meta Has Quietly Become One of Microsoft’s Largest AI Customers - Yahoo Finance
Meta's trial challenges the greed of tech platforms - Le Monde.fr
Chamath Palihapitiya Says Mark Zuckerberg Knows ‘Great Engineers’ Want to Join ‘Space/Search/AI’ Companies, Not Meta’s Advertising Machine - Yahoo Finance
Mark Zuckerberg's Meta Saw Free Cash Flow Plunge 91% to Just $784 Million as AI Spending Ballooned. Here's Why That Should Worry Investors. - The Globe and Mail
What's Going On With Meta Platforms Stock Thursday?Meta Platforms (NASDAQ:META) - Benzinga
Meta Platforms, Inc. $META Stock Holdings Reduced by TB Alternative Assets Ltd. - MarketBeat
Northeast Investment Management Grows Stock Holdings in Meta Platforms, Inc. $META - MarketBeat
Meta Platforms, Inc. $META Shares Bought by San Luis Wealth Advisors LLC - MarketBeat
Reyes Financial Architecture Inc. Acquires 1,441 Shares of Meta Platforms, Inc. $META - MarketBeat
Former Meta employee says company put profit ahead of child safety - Türkiye Today
Crossmark Global Holdings Inc. Sells 3,717 Shares of Meta Platforms, Inc. $META - MarketBeat
Meta Platforms, Inc. $META Shares Sold by Activest Wealth Management - MarketBeat
Meta faces a $1.4 trillion threat that could mean ‘turning in the keys and walking away’ - Fortune
Local expert discusses 'addictive' social media designs amidst META trial - KTVB
Meta: The Drawdown Is An Opportunity - Seeking Alpha
BNP Paribas: Meta (META.US) has promising revenue potential from computing power monetization, with cloud services offering growth prospects beyond advertising. - Moomoo
Former Meta engineer says Instagram took a 'don't ask, don't tell' approach on kids under 13 in lawsuit testimony - ABC7 New York
Washington Post. . Dozens of states are suing Meta Platforms Inc. for harming young people and contributing to the youth mental health crisis by designing features on Instagram and Facebook that addict children to its platforms. Meta has rejected the states’ cl - facebook.com
In Meta's trial, families of social media victims see a pivotal moment for online safety - WRAL
Meta ran ads for an app that only needs one photo and no consent - thestreet.com
Former Meta Engineer Arturo Béjar Testifies Mark Zuckerberg Put Profits Over Child Safety - KQED
Ex-Meta staffer says daughter, 14, was prey on Instagram - The Japan Times
Social media safety tools were ‘designed to fail,’ former Meta engineer testifies - Courthouse News
What the social media addiction lawsuit could cost Meta - Al Jazeera
Mark Zuckerberg encouraged growth over child safety, ex-Meta executive testifies at trial - Reuters
Whistleblower Arturo Béjar leads testimony in landmark trial against Meta - NPR
‘This is about our children’: Landmark Meta trial begins for lawsuit filed by dozens of states - The Washington Post
Meta sued for allegedly firing manager who refused to sign an ‘inaccurate’ immigration letter - HR Dive
Child safety was an afterthought, ex-Meta engineer tells trial - The Times
ICE bars Meta glasses among employees, but hopes to build its own wearable devices - Mashable
Former Meta engineer says Instagram took a 'don't ask, don't tell' approach on kids under 13 - Spectrum News
Zuckerberg lied about concern for child safety, Meta whistleblower testifies at landmark trial - The Guardian
‘Safety became an afterthought’: Former Meta engineer testifies against Zuckerberg as trial begins - Firstpost
Old North State Trust, LLC's Meta Platforms Inc(META) Holding History - GuruFocus
Zuckerberg did not make child safety a priority at Meta, former engineer testifies - The Spokesman-Review
Colorado AG sues Meta over alleged harm - Alamosa Citizen
Former Meta employee testifies in high-profile social media trial - NBC Bay Area
Ex-Meta Staffer Testifies Daughter, 14, Was Prey on Instagram - Yahoo Finance
Prediction: The Child Safety Trial Will Have Minimal Impact on Meta Platforms Stock in the Long Run. Here's Why - Yahoo Finance
Meta Stock Climbs as Landmark Trial Threatens $1.4 Trillion Penalties - inkl
Meta: If You’re Bearish Now, You’re Selling At The Bottom (NASDAQ:META) - Seeking Alpha
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
Meta Platforms Inc-Aktie (META) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| White Dana | Director |
Aug 15 '26 |
Option Exercise |
0.00 |
110 |
0 |
1,504 |
| Arnold John Douglas | Director |
Aug 15 '26 |
Option Exercise |
0.00 |
167 |
0 |
3,329 |
| Elkann John | Director |
Aug 15 '26 |
Option Exercise |
0.00 |
110 |
0 |
1,453 |
| LI SUSAN J | Chief Financial Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
13,957 |
0 |
29,304 |
| LI SUSAN J | Chief Financial Officer |
Aug 15 '26 |
Sale |
689.85 |
2,127 |
1,467,311 |
15,347 |
| Anderson Aaron | Chief Accounting Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
2,448 |
0 |
10,727 |
| Cox Christopher K | Chief Product Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
16,388 |
0 |
272,643 |
| Collison Patrick | Director |
Aug 15 '26 |
Option Exercise |
0.00 |
103 |
0 |
1,166 |
| Bosworth Andrew | Chief Technology Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
16,389 |
0 |
16,803 |
| Mahoney Curtis J. | Chief Legal Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
4,757 |
0 |
5,875 |
0.04%
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):